title: RE-LYing on dabigatran for periprocedural anticoagulation: is it safe?
authors.affiliation: Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina.
authors.forename: Ayotunde
authors.initials: A
authors.lastname: Bamimore
authors.forename: John P
authors.initials: JP
authors.lastname: Mounsey
mesh_terms: D001281:Atrial Fibrillation / Q000601:surgery*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D005260:Female; D006801:Humans; D020766:Intracranial Embolism / Q000453:epidemiology* / Q000517:prevention & control*; D020767:Intracranial Thrombosis / Q000453:epidemiology* / Q000517:prevention & control*; D008297:Male; D014859:Warfarin / Q000627:therapeutic use*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran